bioRxivMolecular BiologyPreprint
AGAL misprocessing-induced ER stress and the unfolded protein response: lysosomal storage-independent mechanism of Fabry disease pathogenesis?
Martina ŽivnáiD, Gabriela DostálováiD, Veronika BarešováiD, Dita MušálkováiD, Ladislav KuchařiD, Befekadu AsfawiD, Helena PoupětováiD, Hana VláškováiD, Tereza KmochováiD, Petr VyleťaliD, Hana HartmannováiD, Kateřina HodaňováiD, Viktor StráneckýiD, Lenka Steiner MrazovaiD, Aleš Hnı́zdaiD, Martin RadinaiD, Miroslav VotrubaiD, Jana Sovová, Helena TrešlováiD, Larisa Stolnaja, Petra RekováiD, Lenka RoblováiD, Eva Honsová, Helena HůlkováiD, Ivan RychlíkiD, , Stanislav KmochiD
- Citations
- 6
Abstract
BackgroundClassic Fabry disease (FD) is caused by GLA mutations that result in enzymatic deficiency of alpha-galactosidase A (AGAL), lysosomal storage of globotriaosylceramide, and a resulting multisystemic disease. In non-classic later-onset FD, patients have some preserved AGAL activity and a milder disease course, though female carriers may also be affected. While FD pathogenesis has been mostly attributed to catalytic deficiency of mutated AGAL, lysosomal storage and impairment of lysosomal functions, other pathogenic factors may be important, especially in non-classic later-onset FD. MethodsWe characterized the clinical, biochemical, genetic, molecular, cellular and organ pathology correlates of the p.L394P AGAL variant that was identified in six individuals with end-stage kidney disease by the Czech national screening program for FD and by further screening of 25 family members. ResultsClinical findings revealed a milder clinical course with ~15% residual AGAL activity. Laboratory investigations documented intracellular retention of mutated AGAL with resulting ER stress and the unfolded protein response (UPR). Kidney biopsies did not show lysosomal storage. We observed similar findings of ER stress and UPR with several other classic and non-classic FD missense GLA variants. ConclusionsWe identified defective proteostasis of mutated AGAL resulting in chronic ER stress and UPR of AGAL expressing cells (hereafter referred to as AGALopathy) as an important contributor to FD pathogenesis. These findings provide insight into non-classic later-onset FD and may better explain clinical manifestations with implications for pathogenesis, clinical characterization and treatment of all FD forms. Significance statementCatalytic deficiency of mutated AGAL is responsible for classicFabry disease (FD) pathogenesis but does not fully explain the findings in non-classic later-onset FD, in which affected individuals and female carriers develop clinical manifestations despite some AGAL activity and variably mitigated lysosomal storage. In this investigation of individuals with the p.L394P AGAL variant, we identified defective proteostasis of mutated AGAL resulting in chronic endoplasmic reticulum stress and the unfolded protein response as significant contributors to pathogenesis of non-classic later-onset FD. Similar effects were documented also in other AGAL variants identified in classic and non-classicFD. Endoplasmic reticulum stress and the unfolded protein response therefore play an important role in FD.
- organism: human
- assay: proteomics
- research focus: cell type annotation
- research focus: differential expression
- approach: statistical model
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Sex differences in alpha galactosidase protein processing and its impact on disease severity in Fabry disease
Lucia Lavalle, Hibba Kurdi, … Derralynn A. Hughes·Molecular Genetics and MetabolismPeer-reviewed·Jan 30, 2025
- Synuclein alpha accumulation mediates podocyte injury in Fabry nephropathy
Ahmed Abed, Fabian Braun, … TB Huber·bioRxiv·Dec 17, 2021
- Mitochondrial stress in Fabry disease
Lucia Lavalle, Hibba Kurdi, … Derralynn A. Hughes·bioRxiv·Sep 16, 2025
- Early atrial remodelling drives arrhythmia in Fabry Disease
Ashwin Roy, Christopher O’Shea, … Richard Paul Steeds·Circulation Arrhythmia and ElectrophysiologyPeer-reviewed·Jun 25, 2025
- Challenging the Conventional Treatment Initiation Paradigm: Early Detection of Irreversible Cellular Damage in Cardiac Biopsies of Fabry Disease Before the Formation of Gb3 Inclusion Bodies
Chung‐Lin Lee, Pei-Sin Chen, … Dau‐Ming Niu·medRxiv·Aug 7, 2023
- Early mitophagy defects and impaired mitochondrial energy metabolism drive target organ damage progression: lessons from the Fabry heart
Jessica Gambardella, Antonella Fiordelisi, … Guido Iaccarino·Cell ReportsPeer-reviewed·Oct 26, 2026